A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1992
11/12/1992	WO1992019733A1 Thyroidal receptor for n-acetylglucosamine
11/12/1992	WO1992019720A1 Immunogenic recombinant strains of b. anthracis and immunogenic compositions containing same
11/12/1992	WO1992019649A1 Antigens recognized by antibodies of rhumatoid polyarthritis, and preparation and use thereof
11/12/1992	WO1992019646A1 Analog of endothelial leukocyte adhesion molecule (elam)
11/12/1992	WO1992019639A1 Glycosylated prodrugs, method of preparation and use
11/12/1992	WO1992019633A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
11/12/1992	WO1992019280A1 Antivenom immunesera
11/12/1992	WO1992019269A1 Antibody recognizing endothelial cell ligand for leukocyte cr3
11/12/1992	WO1992019268A1 New hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
11/12/1992	WO1992019266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof
11/12/1992	WO1992019263A1 Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
11/12/1992	WO1992019244A2 A method for treating infectious respiratory diseases
11/12/1992	WO1992019239A1 Treatment of aberrant cellular states with biomodulators
11/12/1992	WO1992019236A1 2-alkylidene-aminoguanidines for inhibiting advanced nonenzymaticglycosylation of proteins
11/12/1992	WO1992019195A1 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
11/12/1992	WO1992015276A3 Therapeutic and cosmetic compositions for treatment of skin
11/12/1992	CA2109528A1 A method for treating infectious respiratory diseases
11/12/1992	CA2109527A1 Amino-acid sequence homologies between selectins and b pertussis toxin-peptides derived therefrom, antibodies thereto and pharmaceutical compositions
11/12/1992	CA2109332A1 Antibody recognizing endothelial cell ligand for leukocyte cr3
11/12/1992	CA2109090A1 Immunoassay for detecting group b streptococcus
11/12/1992	CA2108451A1 Novel antibodies, and methods for their use
11/12/1992	CA2108029A1 Glycam-1(sgp 50), a selectin ligand
11/12/1992	CA2084876A1 Antigens specifically recognized by specific antibodies of rheumatoid arthritis, their constituent proteins, preparation and applications
11/11/1992	WO1992021031A1 PROCEDURE FOR DETECTING AND PREPARING ANTI-IgE AUTOANTIBODIES AND USE OF THESE ANTIBODIES AS ACTIVE AGENTS IN DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS
11/11/1992	EP0512905A2 Heterobifunctional antibodies possessing both catalytic and specific antigen binding properties and methods using them
11/11/1992	EP0512824A1 Anti-bacterial compound
11/11/1992	EP0512301A1 Method for detecting inflammation
11/11/1992	EP0512260A2 Stable pura vectors and uses thereof
11/11/1992	EP0512023A1 Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
11/11/1992	EP0303687B1 Compositions for enhancing adcc therapy
11/11/1992	CN1065997A 疫苗 Vaccine
11/11/1992	CA2102800A1 Control of milk secretion
11/11/1992	CA2086605A1 Procedure for detecting and preparing anti-ige autoantibodies and use of these antibodies as active agents in diagnostic and therapeutic compositions
11/10/1992	US5162515 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
11/10/1992	US5162512 Treatment of cellular disorders
11/10/1992	US5162302 Thyroid Hormone, Growth Hormone Releasing Factor or Thyrotropin Releasing Hormone
11/10/1992	US5162226 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
11/10/1992	US5162112 Influenza vaccine
11/10/1992	CA1309959C Parathryoid-specific radioimaging techniques
11/09/1992	WO1992019267A1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
11/07/1992	WO1992019273A1 Detection of cardiovascular lesions
11/04/1992	WO1992019752A1 Rna delivery vector
11/04/1992	WO1992019259A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis
11/04/1992	EP0511917A1 Glycosylated prodrugs, process for their preparation and uses thereof
11/04/1992	EP0511855A1 HBsAg escape mutant vaccine
11/04/1992	EP0511854A1 Multiple hepatitis B virus surface proteins which form particles
11/04/1992	EP0511747A1 Hybrid polypeptide containing an avidin binding polypeptide
11/04/1992	EP0511306A1 Tumor killing effects of enterotoxins and related compounds
11/04/1992	EP0511300A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
11/04/1992	EP0511271A1 Thiazole derivatives
11/04/1992	EP0511270A1 New thiazole derivatives
11/04/1992	EP0138854B1 Antigenically active amino acid sequences
11/04/1992	CN1065867A Peptides and mixtures thereof for detecting antibodies to hepatitis c virus
11/04/1992	CA2108886A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis
11/04/1992	CA2086510A1 Rna delivry vector
11/03/1992	WO1992019265A1 Recombinant dna-derived cholera toxin subunit analogs
11/03/1992	US5160725 Magnetic liquid compositions
11/03/1992	CA2102105A1 Recombinant dna-derived cholera toxin subunit analogs
11/03/1992	CA2067598A1 Recombinant adn molecules coding for a receptor chain for the t-cell antigen, preparation process, antibody and drugs containing them
11/03/1992	CA1309804C Purification by affinity binding to liposomes
11/03/1992	CA1309670C Monoclonal antibodies to mucin-like human differentiation antigens
11/03/1992	CA1309655C Immunotoxin therapy of allergy
11/02/1992	WO1992019725A1 Human rotavirus hcr3, reassortants thereof and vaccine compositions containing them
11/02/1992	CA2085597A1 Human rotavirus hcr3, reassortants thereof and vaccine compositions containing them
10/1992
10/30/1992	CA2067590A1 Multiple hepatitis b virus surface proteins which form particles
10/30/1992	CA2067290A1 Hepatitis b virus surface proteins with reduced host carbohydrate content
10/30/1992	CA2067003A1 Hbsag escape mutant vaccine
10/29/1992	WO1992018652A1 Process of screening plasma samples for effective antibody titers against respiratory viruses
10/29/1992	WO1992018627A1 Glial mitogenic factors, their preparation and use
10/29/1992	WO1992018626A1 WATER-SOLUBLE POLYPEPTIDES HAVING HIGH AFFINITY FOR INTERFERONS α AND $g(b)
10/29/1992	WO1992018624A1 Plasmides for the expression of filamentous haemagglutinin (fha) and hosts therefor
10/29/1992	WO1992018610A2 Compositions and methods for endothelial binding
10/29/1992	WO1992018534A1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1992	WO1992018532A1 Rna, dna and virus antigen protein of non-a non-b hepatitis virus
10/29/1992	WO1992018530A1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN
10/29/1992	WO1992018162A1 Anti-idiotypic monoclonal antibodies for mucoid pseudomonas aeruginosa, their preparation and use
10/29/1992	WO1992018161A1 Production of vaccines
10/29/1992	WO1992018150A1 Mhc conjugates useful in ameliorating autoimmunity
10/29/1992	WO1992018147A1 Convertible microemulsion formulations
10/29/1992	WO1992018140A1 Activity-dependent neurotrophic factor
10/29/1992	WO1992018113A1 Identification of a new ehrlichia species from a patient suffering from ehrlichiosis
10/29/1992	WO1992018004A1 ABROGATION OF VIRAL RESISTANCE TO NUCLEOSIDE ANALOGUES BY DOUBLE-STRANDED RNAs
10/29/1992	WO1992016623A3 Receptors for bombesin-like peptides
10/29/1992	WO1992011370A3 Polypeptides derived from proteins of the hepatitis c virus
10/29/1992	DE4113385A1 Hybridtransposon mit pt-operon, plasmide und bakterienstaemme dafuer Hybrid transposon with pt-operon, plasmids and bakterienstaemme for it
10/29/1992	DE4111531A1 Plasmide zur fha-expression und wirte Plasmids for fha-expression and wirte
10/29/1992	CA2585487A1 Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons
10/29/1992	CA2108786A1 Compositions and methods for endothelial binding
10/29/1992	CA2102221A1 Abrogation of viral resistance to nucleoside analogues by double-stranded rnas
10/28/1992	EP0511116A1 Antigens recognized by polyarthrits rheumatoid antibodies, preparation and applications
10/28/1992	EP0511011A1 Novel antibodies and methods for their use
10/28/1992	EP0510996A1 Recombinant varicella-zoster virus vector
10/28/1992	EP0510949A2 Cytomodulating conjugates of members of specific binding pairs
10/28/1992	EP0510902A1 Immunoassay for detecting group B streptococcus
10/28/1992	EP0510773A1 Canine coronavirus subunit vaccine
10/28/1992	EP0510356A1 Polyethylene glycol protein conjugates
10/28/1992	EP0510186A1 Therapeutic uses of melanin
10/28/1992	EP0510079A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
10/28/1992	EP0510075A1 Human receptor of tsh. sequence coding for such receptor
10/28/1992	EP0510054A1 Hiv-1 core protein fragments

1 ... 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 ... 1823